Contact this trialFirst, we need to learn more about you.
Anti-epileptic
Levetiracetam for Psychosis
Recruiting0 awardsPhase 2
Nashville, Tennessee
This trial will test whether the anti-epileptic drug levetiracetam can reduce hippocampal hyperactivity in people with psychotic disorders, in order to better understand the role of the hippocampus in psychosis.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.